Title : A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies.

Pub. Date : 2016 Apr 12

PMID : 27002938






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies. OSI 027 CREB regulated transcription coactivator 2 Mus musculus
2 CONCLUSIONS: OSI-027 inhibits mTORC1/2 in patients with advanced tumour s in a dose-dependent manner but doses above the tolerable levels in S1 and S3 are required for a sustained biological effect in tumour biopsies. OSI 027 CREB regulated transcription coactivator 2 Mus musculus